In the global race for the coronavirus vaccine, Oxford University made a leap forward.
Human trials are already underway and scientists are hoping that the vaccine will be widely available by September.
Earlier, the university laboratory developed technology to create vaccines against other diseases, including those close to COVID-19, which gave it a head start.
“I personally believe very much in this vaccine because I have used this technology before,” said Vaccine Professor Sarah Gilbert.
The vaccine uses genetic material from coronavirus, which is injected into a common cold virus that has been previously neutralized so that it cannot spread to humans. The modified virus simulates COVID-19, mobilizing the immune system to fight an impostor, thus providing protection against the real coronavirus.